221 related articles for article (PubMed ID: 21028795)
1. Advances in proximal fluid proteomics for disease biomarker discovery.
Teng PN; Bateman NW; Hood BL; Conrads TP
J Proteome Res; 2010 Dec; 9(12):6091-100. PubMed ID: 21028795
[TBL] [Abstract][Full Text] [Related]
2. Proteome studies of CSF in AD patients.
Davidsson P; Sjögren M
Mech Ageing Dev; 2006 Feb; 127(2):133-7. PubMed ID: 16293296
[TBL] [Abstract][Full Text] [Related]
3. Biomarker discovery for kidney diseases by mass spectrometry.
Niwa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
[TBL] [Abstract][Full Text] [Related]
4. Derivatized mesoporous silica beads for MALDI-TOF MS profiling of human plasma and urine.
Terracciano R; Pasqua L; Casadonte F; Frascà S; Preianò M; Falcone D; Savino R
Bioconjug Chem; 2009 May; 20(5):913-23. PubMed ID: 19338374
[TBL] [Abstract][Full Text] [Related]
5. Biomarker discovery from the plasma proteome using multidimensional fractionation proteomics.
Lee HJ; Lee EY; Kwon MS; Paik YK
Curr Opin Chem Biol; 2006 Feb; 10(1):42-9. PubMed ID: 16418010
[TBL] [Abstract][Full Text] [Related]
6. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
Ekegren T; Hanrieder J; Bergquist J
J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
[TBL] [Abstract][Full Text] [Related]
7. Plasma-derived microparticles for biomarker discovery.
Smalley DM; Ley K
Clin Lab; 2008; 54(3-4):67-79. PubMed ID: 18630736
[TBL] [Abstract][Full Text] [Related]
8. The proteomic advantage: label-free quantification of proteins expressed in bovine milk during experimentally induced coliform mastitis.
Boehmer JL; DeGrasse JA; McFarland MA; Tall EA; Shefcheck KJ; Ward JL; Bannerman DD
Vet Immunol Immunopathol; 2010 Dec; 138(4):252-66. PubMed ID: 21067814
[TBL] [Abstract][Full Text] [Related]
9. Global and targeted quantitative proteomics for biomarker discovery.
Veenstra TD
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
[TBL] [Abstract][Full Text] [Related]
10. Sub-speciating Campylobacter jejuni by proteomic analysis of its protein biomarkers and their post-translational modifications.
Fagerquist CK; Bates AH; Heath S; King BC; Garbus BR; Harden LA; Miller WG
J Proteome Res; 2006 Oct; 5(10):2527-38. PubMed ID: 17022624
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective.
Alvarez-Llamas G; de la Cuesta F; Barderas ME; Darde V; Padial LR; Vivanco F
Expert Rev Proteomics; 2008 Oct; 5(5):679-91. PubMed ID: 18937558
[TBL] [Abstract][Full Text] [Related]
12. Advanced proteomic technologies for cancer biomarker discovery.
Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
[TBL] [Abstract][Full Text] [Related]
13. Data management and functional annotation of the Korean reference plasma proteome.
Jeong SK; Lee EY; Cho JY; Lee HJ; Jeong AS; Cho SY; Paik YK
Proteomics; 2010 Mar; 10(6):1250-5. PubMed ID: 20175082
[TBL] [Abstract][Full Text] [Related]
14. Towards the application of proteomics in renal disease diagnosis.
Vidal BC; Bonventre JV; I-Hong Hsu S
Clin Sci (Lond); 2005 Nov; 109(5):421-30. PubMed ID: 16232126
[TBL] [Abstract][Full Text] [Related]
15. Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display.
Tammen H; Schulte I; Hess R; Menzel C; Kellmann M; Mohring T; Schulz-Knappe P
Proteomics; 2005 Aug; 5(13):3414-22. PubMed ID: 16038021
[TBL] [Abstract][Full Text] [Related]
16. Development of an antibody proteomics system using a phage antibody library for efficient screening of biomarker proteins.
Imai S; Nagano K; Yoshida Y; Okamura T; Yamashita T; Abe Y; Yoshikawa T; Yoshioka Y; Kamada H; Mukai Y; Nakagawa S; Tsutsumi Y; Tsunoda S
Biomaterials; 2011 Jan; 32(1):162-9. PubMed ID: 20933274
[TBL] [Abstract][Full Text] [Related]
17. Differential proteomic analysis of renal cell carcinoma tissue interstitial fluid.
Teng PN; Hood BL; Sun M; Dhir R; Conrads TP
J Proteome Res; 2011 Mar; 10(3):1333-42. PubMed ID: 21142074
[TBL] [Abstract][Full Text] [Related]
18. Detection of new screening markers for fetal aneuploidies in maternal plasma: a proteomic approach.
Reddy CS; Holzgreve W; Hahn S
Methods Mol Biol; 2008; 444():311-26. PubMed ID: 18425492
[TBL] [Abstract][Full Text] [Related]
19. Achieving in-depth proteomics profiling by mass spectrometry.
Ahn NG; Shabb JB; Old WM; Resing KA
ACS Chem Biol; 2007 Jan; 2(1):39-52. PubMed ID: 17243782
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of human cervico-vaginal fluid.
Shaw JL; Smith CR; Diamandis EP
J Proteome Res; 2007 Jul; 6(7):2859-65. PubMed ID: 17567164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
